Scientific Commercialization provides innovative consulting and analytic software services to Medical Affairs and other functions within life sciences and biotechnology companies.
Our core competencies:
Technology Selection & Implementation
Fifteen years later, SC is focused on two primary offerings: • Strategic advisory services to Medical Affairs leadership teams • Business Intelligence solutions to drive evidence-based decision-making
Meet the Leadership Team
Daniel Leonard, MS
Mark LaLeike, MS
Jason Jensen, MBA
Steven P. Jones, MBA
Kay Uttech, PharmD, MA, BCPS
Art Kerwin, J.D.
Click here to download a PDF of this post
SC will be attending the annual Medical Affairs Strategic Summit (MASS) West in San Diego September 25-27th. We look forward to seeing our current clients and networking with other industry leaders. If you’re also planning on attending, let us know in a comment below so we can be sure to say hello!
Medical Affairs organizations collect large amounts of unstructured data through a number of channels – more data than Medical Affairs leaders might even be aware of. Natural Language Processing (NLP) is a great application for unlocking this data. We were curious how companies were using NLP for free text analysis and what obstacles they had[…]
Medical Affairs leaders who attended last week’s MAPS conference discussed perspectives on the benefits and challenges of measuring how their organizations add value. In this blog post, Scientific Commercialization’s Managing Director Mark LaLeike shares what he heard at the conference and invites readers to comment regarding Medical Affairs’ challenges in measuring value. Use the link[…]
Madison, WI – Scientific Commercialization LLC, a leader in Life Sciences Consulting Services and Business Intelligence Solutions, is pleased to announce Kay Uttech, PharmD, MA, BCPS has joined the Company as Manager. In her role as Manager, Dr. Uttech is responsible for helping shape Scientific Commercialization’s services/solutions to meet the needs of Medical Affairs leaders[…]
Our latest blog post, Medical Affairs Must Pivot Toward Payers, describes the most recent Scientific Commercialization research – “How Can Medical Affairs Optimize Market Access Impact?” Through a series of interviews with US-based Market Access and Medical Affairs leaders representing a variety of global biopharmaceutical companies, Scientific Commercialization solicited input on the top challenges and opportunities[…]
Our latest blog post, When Do I Need to Start Medical Affairs for My Late-Stage Development Company, addresses the questions our clients often face when making decisions on the sequence and timing of Medical Affairs investment. Using three sample Scientific Commercialization client cases across three different therapeutic areas, we review the general approaches and outcomes[…]
We recently completed another project addressing “legal obstacles” between Medical Affairs and other company functional groups. This project began when our team discussed issues surrounding collaboration and work between groups with company stakeholders. A fairly typical exchange reported to us looked like this: Commercial leader: Now that we’ve launched our product, I’d like to make[…]
Natural Language Processing (NLP) is a field of computer science that deals with applying linguistic and statistical algorithms to text in order to extract meaning in a way that is very similar to how the human brain understands language. NLP has potential to be a significant asset to Medical Affairs organizations. To learn more, use the link[…]